Publications | Page 5 | Cervo Brain Research Centre

Export 9 results:

Filters: Author is Bareil, Christine [Clear All Filters]

2020

K. Dutta, Thammisetty, S. Sampath, Boutej, H., Bareil, C., and J-P Julien, “Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling.”, J Neurosci, vol. 40, no. 26, pp. 5137-5154, 2020.

S. Pozzi, Codron, P., Soucy, G., Renaud, L., Cordeau, P., Dutta, K., Bareil, C., and J-P Julien, “Monoclonal full-length antibody against TAR DNA-binding protein 43 reduces related proteinopathy in neurons.”, JCI Insight, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid”, Acta neuropathologica communications, vol. 8, no. 1, pp. 65 - 65, 2020.

P. Shree Mishra, Boutej, H., Soucy, G., Bareil, C., Kumar, S., Picher-Martel, V., Dupré, N., Kriz, J., and J-P Julien, “Transmission of ALS pathogenesis by the cerebrospinal fluid.”, Acta Neuropathol Commun, vol. 8, no. 1, p. 65, 2020.

2019

S. Pozzi, Thammisetty, S. Sampath, Codron, P., Rahimian, R., Plourde, K. Valérie, Soucy, G., Bareil, C., Phaneuf, D., Kriz, J., Gravel, C., and J-P Julien, “Virus-mediated delivery of antibody targeting TAR DNA-binding protein-43 mitigates associated neuropathology.”, J Clin Invest, vol. 129, no. 4, pp. 1581-1595, 2019.

2018

V. Picher-Martel, Renaud, L., Bareil, C., and J-P Julien, “Neuronal Expression of UBQLN2 Exacerbates TDP-43 Pathology in TDP-43 Mice through Interaction with Ubiquitin.”, Mol Neurobiol, 2018.

2016

Y. Iguchi, Eid, L., Parent, M., Soucy, G., Bareil, C., Riku, Y., Kawai, K., Takagi, S., Yoshida, M., Katsuno, M., Sobue, G., and J-P Julien, “Exosome secretion is a key pathway for clearance of pathological TDP-43.”, Brain, vol. 139, no. Pt 12, pp. 3187-3201, 2016.

2014

P. Patel, Kriz, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., and J-P Julien, “Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.”, Mol Ther, vol. 22, no. 3, pp. 498-510, 2014.

2011

V. Swarup, Phaneuf, D., Bareil, C., Robertson, J., Rouleau, G. A., Kriz, J., and J-P Julien, “Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.”, Brain, vol. 134, no. Pt 9, pp. 2610-26, 2011.

Funding / Support / Partners

© Gouvernement du Québec